Literature DB >> 17940199

Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons.

Juan Guo1, Damian J Williams, Henry L Puhl, Stephen R Ikeda.   

Abstract

GPR35 is a G protein-coupled receptor recently "de-orphanized" using high-throughput intracellular calcium measurements in clonal cell lines expressing a chimeric G-protein alpha-subunit. From these screens, kynurenic acid, an endogenous metabolite of tryptophan, and zaprinast, a synthetic inhibitor of cyclic guanosine monophosphate-specific phosphodiesterase, emerged as potential agonists for GPR35. To investigate the coupling of GPR35 to natively expressed neuronal signaling pathways and effectors, we heterologously expressed GPR35 in rat sympathetic neurons and examined the modulation of N-type (Ca(V)2.2) calcium channels. In neurons expressing GPR35, calcium channels were inhibited in the absence of overt agonists, indicating a tonic receptor activity. Application of kynurenic acid or zaprinast resulted in robust voltage-dependent calcium current inhibition characteristic of Gbetagamma-mediated modulation. Both agonist-independent and -dependent effects of GPR35 were blocked by Bordetella pertussis toxin pretreatment indicating the involvement of G(i/o) proteins. In neurons expressing GPR35a, a short splice variant of GPR35, zaprinast was more potent (EC(50) = 1 microM) than kynurenic acid (58 microM) but had a similar efficacy (approximately 60% maximal calcium current inhibition). Expression of GPR35b, which has an additional 31 residues at the N terminus, produced similar results but with much greater variability. Both GPR35a and GPR35b appeared to have similar expression patterns when fused to fluorescent proteins. These results suggest a potential role for GPR35 in regulating neuronal excitability and synaptic release.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940199     DOI: 10.1124/jpet.107.127266

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  28 in total

1.  Crucial positively charged residues for ligand activation of the GPR35 receptor.

Authors:  Pingwei Zhao; Tom R Lane; Helen G L Gao; Dow P Hurst; Evangelia Kotsikorou; Long Le; Eugen Brailoiu; Patricia H Reggio; Mary E Abood
Journal:  J Biol Chem       Date:  2013-12-17       Impact factor: 5.157

2.  Endogenous activation of nAChRs and NMDA receptors contributes to the excitability of CA1 stratum radiatum interneurons in rat hippocampal slices: effects of kynurenic acid.

Authors:  Manickavasagom Alkondon; Edna F R Pereira; Edson X Albuquerque
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

3.  High-throughput identification and characterization of novel, species-selective GPR35 agonists.

Authors:  Zaynab Neetoo-Isseljee; Amanda E MacKenzie; Craig Southern; Jeff Jerman; Edward G McIver; Nicholas Harries; Debra L Taylor; Graeme Milligan
Journal:  J Pharmacol Exp Ther       Date:  2012-12-21       Impact factor: 4.030

4.  GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?

Authors:  Soo-Jin Park; Seung-Jin Lee; So-Yeon Nam; Dong-Soon Im
Journal:  Br J Pharmacol       Date:  2017-12-08       Impact factor: 8.739

Review 5.  Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.

Authors:  Jasenka Zubcevic; Elaine M Richards; Tao Yang; Seungbum Kim; Colin Sumners; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

6.  Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.

Authors:  Pingwei Zhao; Haleli Sharir; Ankur Kapur; Alan Cowan; Ellen B Geller; Martin W Adler; Herbert H Seltzman; Patricia H Reggio; Susanne Heynen-Genel; Michelle Sauer; Thomas D Y Chung; Yushi Bai; Wei Chen; Marc G Caron; Larry S Barak; Mary E Abood
Journal:  Mol Pharmacol       Date:  2010-07-22       Impact factor: 4.436

7.  N-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca2+ channels in sympathetic neurons.

Authors:  Juan Guo; Damian J Williams; Stephen R Ikeda
Journal:  J Neurophysiol       Date:  2008-01-30       Impact factor: 2.714

8.  N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways.

Authors:  Van B Lu; Henry L Puhl; Stephen R Ikeda
Journal:  Mol Pharmacol       Date:  2012-10-25       Impact factor: 4.436

9.  Inhibition of mitochondrial pyruvate transport by zaprinast causes massive accumulation of aspartate at the expense of glutamate in the retina.

Authors:  Jianhai Du; Whitney M Cleghorn; Laura Contreras; Ken Lindsay; Austin M Rountree; Andrei O Chertov; Sally J Turner; Ayse Sahaboglu; Jonathan Linton; Martin Sadilek; Jorgina Satrústegui; Ian R Sweet; François Paquet-Durand; James B Hurley
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

10.  Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons.

Authors:  Peter Dobelis; Kevin J Staley; Donald C Cooper
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.